Head-To-Head Comparison: LONMIN PLC/S (OTCMKTS:LNMIY) and Eisai (OTCMKTS:ESALY)

LONMIN PLC/S (OTCMKTS:LNMIY) and Eisai (OTCMKTS:ESALY) are both basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation and risk.

Institutional & Insider Ownership

0.0% of Eisai shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent recommendations and price targets for LONMIN PLC/S and Eisai, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LONMIN PLC/S	0	0	0	0	N/A
Eisai	0	0	2	0	3.00

Risk and Volatility

LONMIN PLC/S has a beta of 2.75, suggesting that its stock price is 175% more volatile than the S&P 500. Comparatively, Eisai has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500.

Earnings & Valuation

This table compares LONMIN PLC/S and Eisai’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LONMIN PLC/S	$1.35 billion	0.21	$42.00 million	N/A	N/A
Eisai	$6.74 billion	2.62	$426.79 million	$0.87	70.70

Eisai has higher revenue and earnings than LONMIN PLC/S.

Profitability

This table compares LONMIN PLC/S and Eisai’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LONMIN PLC/S	N/A	N/A	N/A
Eisai	4.11%	3.86%	2.50%

Summary

Eisai beats LONMIN PLC/S on 8 of the 9 factors compared between the two stocks.

About LONMIN PLC/S

Lonmin Plc explores, mines, refines, and markets platinum group metals in South Africa, the Americas, Asia, and Europe. The company explores for platinum, palladium, rhodium, iridium, ruthenium, and gold, as well as chrome, nickel, copper, and cobalt deposits. Its flagship property is the Marikana mine located on the Western Limb of the Bushveld igneous complex in South Africa. In addition, the company holds 100% interest in Pandora mine. The company was founded in 1909 and is headquartered in Melrose North, South Africa.

About Eisai

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.